Journals / Turkish Journal of Hematology / 2016 / Cilt: 33 - Sayı: 4

Pediatrik Malignite Hastalarında Varicella Zoster Virüs Enfeksiyonları: Yedi Yıllık Analiz

Varicella-Zoster Virus Infections in Pediatric Malignancy Patients:A Seven-Year Analysis

Pages
346–348
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

VZV infections are still important contagious diseases in pediatric cancer patients, because they cause not only significant mortality but also a delay in chemotherapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Primary varicella-zoster virus (VZV) infection is a benign self-limited disease.
📊
Key Findings & Data:During the study period, a total of 41 patients with pediatric malignancy had been hospitalized with the diagnosis of VZV infection.
💡
Conclusion & Impact:VZV infections are still important contagious diseases in pediatric cancer patients, because they cause not only significant mortality but also a delay in chemotherapy.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Primary varicella-zoster virus (VZV) infection is a benign self-limited disease. In this study, we review our experience in focusing on the outcome and treatment of VZV infection in pediatric malignancy patients. During the study period, a total of 41 patients with pediatric malignancy had been hospitalized with the diagnosis of VZV infection. All the patients were treated with intravenous acyclovir for a median of 7 days (ranging from 5 to 21 days). The calculated attributable delay of chemotherapy due to VZV infections was 8 days (ranging from 2 to 60 days). VZV-related complications were observed in 3 of 41 patients (7%) who suffered from acute respiratory distress syndrome, and one of them with hemophagocytic lymphohistiocytosis died due to respiratory failure despite acyclovir and broad-spectrum antimicrobial treatment plus supportive treatment. VZV infections are still important contagious diseases in pediatric cancer patients, because they cause not only significant mortality but also a delay in chemotherapy.

Özet

Primer varisella zoster virüs (VZV) enfeksiyonu benign, kendi kendini sınırlayan bir hastalıktır. Bu çalışmada pediatrik malignitesi olan hastalarda VZV enfeksiyonu ve tedavisine odaklı tecrübelerimizi gözden geçirmeyi amaçladık. Çalışma süresi boyunca; VZV enfeksiyonu tanısı alan pediatrik maligniteli toplam 41 hasta hastaneye yatırıldı. Tüm hastalar ortalama 7 gün (5 ila 21 gün arasında değişen) intravenöz asiklovir ile tedavi edildi. VZV enfeksiyonlarına bağlı olarak hesaplanan atfedilebilir kemoterapi gecikmesi ortalama 8 gündü (2 ile 60 gün arasında değişen). VZV enfeksiyonuna bağlı komplikasyonlar 41 hastadan 3'ünde (%7) akut solunum distres sendromu olarak görüldü ve bu hastalardan hemofagositik lenfohistiyositozu olan bir tanesi asiklovir, geniş spektrumlu antibiyotik ve destekleyici tedaviye rağmen solunum yetmezliği nedeniyle kaybedildi. VZV enfeksiyonları, pediatrik malignite hastalarında hala önemli bulaşıcı hastalıklardan biridir, çünkü sadece ciddi mortaliteye sebep olmakla kalmayıp kemoterapi başlangıcını da geciktirmektedir.

🔖

Cite This Article

DÜZGÖL, M., ÖZEK, G., BAYRAM, S. N., OYMAK, Y., KARA, A., DEMİRAĞ, B., KARAPINAR, T. H., AY, Y., VERGİN, C., DEVRİM, İ. (2016). Pediatrik Malignite Hastalarında Varicella Zoster Virüs Enfeksiyonları: Yedi Yıllık Analiz. Turkish Journal of Hematology, Cilt: 33 - Sayı: 4, 346–348. https://ajindex.com/articles/412495

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Gunawan S, Linardi P, Tawaluyan K, Mantik MF, Veerman AJ. Varicella outbreak in a pediatric oncology ward: the Manado experience. Asian Pac J Cancer Prev 2010;11:289-292.
  2. Feldman S, Hughes WT, Daniel CB. Varicella in children with cancer: seventy- seven cases. Pediatrics 1975;56:388-397.
  3. Katsimpardi K, Papadakis V, Pangalis A, Parcharidou A, Panagiotou JP, Soutis M, Papandreou E, Polychronopoulou S, Haidas S. Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment. Support Care Cancer 2006;14:277-284.
  4. Matsuzaki A, Suminoe A, Koga Y, Kusuhara K, Hara T, Ogata R, Sata T, Hara T. Fatal visceral varicella-zoster virus infection without skin involvement in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 2008;25:237-242.
  5. Meir HM, Balawi IA, Meer HM, Nayel H, Al-Mobarak MF. Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy. Saudi Med J 2001;22:423-427. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases, 10th ed. Washington DC, Public Health Foundation, 2008. Council of State and Territorial Epidemiologists. Public Health Reporting and National Notification for Varicella. Atlanta, Council of State and Territorial Epidemiologists, 2012. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th ed. Washington DC, Public Health Foundation, 2015.
  6. Buda K, Tubergen DG, Levin MJ. The frequency and consequences of varicella exposure and varicella infection in children receiving maintenance therapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1996;18:106-112.
  7. Alam MM, Qamar FN, Khan ZW, Kumar V, Mushtaq N, Fadoo Z. Risk factors for complicated varicella infection in pediatric oncology patients at a tertiary health care facility in Pakistan. J Infect Dev Ctries 2014;8:215-220.
  8. Ben-Abraham R, Keller N, Vered R, Harel R, Barzilay Z, Paret G. Invasive group A streptococcal infections in a large tertiary center: epidemiology, characteristics and outcome. Infection 2002;30:81-85.
  9. Feldman S, Lott L. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 1987;80:465-472. Escaño-Gallardo ET, Bravo LC. Varicella in immunocompromised children at the Philippine general hospital: a six-year review. PIDSP Journal 2011;12:27-39. Cherry J. Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 5th ed. Philadelp